Breitner J. (2011). Apolipoprotein e, Alzheimer's disease, and amyloid: do we have the cart before the horse?, J Alzheimers Dis, 23(1), 171-172. Find out more.

Breitner J. (2011). Further evidence for vascular mediation of Alzheimer's dementia pathogenesis?, Biol Psychiatry, 70(2), 113-114. Find out more.

Breitner J., Baker L.D., Montine T.J., Meinert C.L., Lyketsos C.G., Ashe K.H., Brandt J., Craft S., Evans D.E., Green R.C., Ismail M.S., Martin B.K., Mullan M.J., Sabbagh M., Tariot P.N. (2011). Extended results of the Alzheimer's disease anti-inflammatory prevention trial, Alzheimers Dement, 7(4), 402-411. Find out more.

Dublin S., Anderson M. L., Haneuse S. J., Heckbert S. R., Crane P. K., Breitner J., McCormick W., Bowen J. D., Teri L., McCurry S. M., Larson E. B. (2011). Atrial fibrillation and risk of dementia: a prospective cohort study, J Am Geriatr Soc, 59(8), 1369-75. Find out more.

Gray S.L., Walker R., Dublin S., Haneuse S., Crane P.K., Breitner J., Bowen J., McCormick W., Larson E.B. (2011). Histamine-2 receptor antagonist use and incident dementia in an older cohort, J Am Geriatr Soc, 59(2), 251-257. Find out more.

Kauwe J. S., Cruchaga C., Karch C. M., Sadler B., Lee M., Mayo K., Latu W., Su'a M., Fagan A. M., Holtzman D. M., Morris J. C., Breitner J., Alzheimer's Disease Neuroimaging Initiative, Goate A. M. (2011). Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease, PLoS One, 6(2), e15918. Find out more.

Mayeux R., Reitz C., Brickman A.M., Haan M.N., Manly J.J., Glymour M.M., Weiss C.C., Yaffe K., Middleton L., Hendrie H.C., Warren L.H., Hayden K.M., Welsh-Bohmer K.A., Breitner J., Morris J.C. (2011). Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1, Alzheimers Dement, 7(1), 15-34. Find out more.

McEvoy L. K., Holland D., Hagler D. J., Fennema-Notestine C., Brewer J. B., Dale A. M., Breitner J., Alzheimer's Disease Neuroimaging Initiative (2011). Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis, Radiology, 259(3), 834-43. Find out more.

Norton M. C., Smith K. R., Ostbye T., Tschanz J. T., Schwartz S., Corcoran C., Breitner J., Steffens D. C., Skoog I., Rabins P. V., Welsh-Bohmer K. A., Cache County Investigators (2011). Early parental death and remarriage of widowed parents as risk factors for Alzheimer disease: the Cache County study, Am J Geriatr Psychiatry, 19(9), 814-24. Find out more.

Tosun D., Schuff N., Mathis C. A., Jagust W., Weiner M. W., Breitner J., Alzheimer's Disease NeuroImaging Initiative (2011). Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment, Brain, 134(Pt 4), 1077-88. Find out more.

Treiber K.A., Carlson M.C., Corcoran C., Norton M.C., Breitner J., Piercy K.W., Deberard M.S., Stein D., Foley B., Welsh-Bohmer K.A., Frye A., Lyketsos C.G., Tschanz J.T. (2011). Cognitive Stimulation and Cognitive and Functional Decline in Alzheimer's Disease: The Cache County Dementia Progression Study, J Gerontol B Psychol Sci Soc Sci. Find out more.

Tschanz J.T., Corcoran C.D., Schwartz S., Treiber K., Green R.C., Norton M.C., Mielke M.M., Piercy K., Steinberg M., Rabins P.V., Leoutsakos J.M., Welsh-Bohmer K.A., Breitner J., Lyketsos C.G. (2011). Progression of Cognitive, Functional, and Neuropsychiatric Symptom Domains in a Population Cohort With Alzheimer Dementia: The Cache County Dementia Progression Study, Am J Geriatr Psychiatry, 19(6), 532-542. Find out more.